Erythropoietin Drugs Market Overview The global erythropoietin drugs market is experiencing robust growth, driven by the rising prevalence of anemia, chronic kidney disease, and cancer-related anemia, along with the increased adoption of biologics in therapeutic regimens. Erythropoietin (EPO) is a glycoprotein hormone responsible for stimulating the production of red blood cells in...